Alpha Tau Medical Ltd

NASDAQ DRTS

Data sourced from iex and EODHD
Download Data

Alpha Tau Medical Ltd Income Statement 2019 - 2024

This table shows the Income Statement for Alpha Tau Medical Ltd going from 2019 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - -
Cost of Revenue
M - 1 - 1 - 1 - - - - - - - - - - - - - - -
Gross Profit
M - -1 - -1 - -1 - - - - - - - - - - - - - - -
Operating Expenses
M - 9 - 8 - 7 - - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 1 2 2 2 2 2 2 2 3 1 1 0 0 0 0 0 0 0 0 0 0
Research and Development (R&D) Expenses
M 6 7 7 6 6 5 5 5 5 3 3 3 2 2 2 2 2 2 2 2 2
Other Operating Expenses
M - -1 - 0 - -1 - - - - - - - - - - - - - - -
Costs and Expenses
M - 8 - 8 - 7 - - - - - - - - - - - - - - -
Operating Income
M -8 -10 -9 -8 -9 -8 -7 -8 -9 -4 -4 -3 -3 -2 -2 -2 -2 -2 -2 -2 -2
Interest Expense
M - - - - 0 8 5 6 17 14 1 3 9 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 0 3 4 0 0 5 5 6 -17 0 -1 -3 -9 0 0 0 0 0 0 0 0
EBT
M -8 -7 -5 -9 -8 -3 -3 -2 -26 -4 -5 -7 -12 -2 -2 -2 -2 -2 -2 -2 -2
Income Tax Provision
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -8 -7 -5 -9 -8 -3 -3 -2 -26 -4 -5 -7 -12 -2 -2 -2 -2 -2 -2 -2 -2
Non-Controlling Interest
M - - - 0 1 0 0 0 0 1 0 2 0 - - - - - - - -
Net Income
M - - - -9 -9 -3 -3 -2 -26 -4 -5 -9 -12 - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 69,714,250.00 69,670,612.00 69,473,825.00 69,315,891.00 69,205,654.00 68,798,251.00 68,798,251.00 68,427,180.00 47,504,979.00 47,504,979.00 67,621,409.00 67,621,409.00 67,621,409.00 67,621,409.00 67,621,409.00 67,621,409.00 67,621,409.00 67,621,409.00 67,621,409.00 67,621,409.00 67,621,409.00
EBITDA
M -8 -9 -9 -8 -9 -8 -7 -8 -9 -4 -4 -3 -3 -2 -2 -2 -2 -2 -2 -2 -2
Depreciation and Amortization
M 0 1 0 1 0 12 9 0 0 14 -2 0 0 0 0 0 0 0 0 0 0
EBIT
M -9 -10 -9 -9 -9 -20 -7 -8 -9 -18 -1 -3 -3 -2 -2 -2 -2 -2 -2 -2 -2
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -0.01 -0.11 0.79 -0.30 -0.26 -0.09 -0.34 -0.30 -0.01 0.37 0.10 -0.22 -0.09 -1.81 -1.81 -1.81 -1.81 -1.76 -1.76 -1.76 -1.76
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 - - - - - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email